Diovan Hct Tablet, Film Coated
Product Images NDC 0078-0472

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Diovan Hct (NDC 0078-0472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure < 140 Mmhg At Week 8 (Diovan Hct 01)

A line graph showing the percentage of subjects with systolic blood pressure (SBP) less than 140 mmHg plotted against baseline SBP values ranging from 140 to 180 mmHg. The graph compares four treatment groups: Diovan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, each represented by different marker styles.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure < 90 Mmhg At Week 8 (Diovan Hct 02)

A line chart comparing the change in diastolic blood pressure (DBP) with baseline DBP among four groups: Diovan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The y-axis shows change in DBP in mmHg and the x-axis shows baseline DBP in mmHg, illustrating the blood pressure-lowering effects of each treatment.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure < 130 Mmhg At Week 8 (Diovan Hct 03)

A line graph depicting the percentage of systolic blood pressure (SBP) responders across baseline SBP levels (140 to 180 mmHg). It compares responses for Diovan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure < 80 Mmhg At Week 8 (Diovan Hct 04)

A line chart comparing the percent reduction in diastolic blood pressure (DBP) at 8 weeks versus baseline DBP in mmHg for different treatments: Diovan HCT 320/25 mg, valsartan 320 mg, hydrochlorothiazide 25 mg, and placebo. The chart includes data points and shows the efficacy of each treatment in lowering DBP.*

FDA Label Image

Valsartan Structural Formula (Diovan Hct 05)

Chemical structure of valsartan, the active ingredient in Diovan HCT tablets that contains valsartan and hydrochlorothiazide. The diagram shows the molecular arrangement of atoms within the valsartan compound.*

FDA Label Image

Hydrochlorothiazide Structural Formula (Diovan Hct 06)

Chemical structure diagram showing a compound with sulfonamide, chloro-substituted aromatic ring, and other chemical groups. This image is identified as the chemical structure of valsartan and hydrochlorothiazide active ingredients.*

FDA Label Image

Principal Display Panel Ndc 0078-0314-34 Diovan Hct® Valsartan And Hydrochlorothiazide, Usp 80 mg/12.5 mg 90 Tablets Rx Only Novartis (Diovan Hct 07)

Diovan HCT 80 mg/12.5 mg film-coated tablets label showing the proprietary name and strength, generic names valsartan and hydrochlorothiazide, USP, packaged as 90 tablets. The label includes storage instructions, manufacturer is Patheon Manufacturing Services LLC, and distributor is Novartis Pharmaceuticals Corporation. The label features a barcode and a Novartis logo.*

FDA Label Image

Principal Display Panel Ndc 0078-0315-34 Diovan Hct® Valsartan And Hydrochlorothiazide, Usp 160 mg/12.5 mg 90 Tablets Rx Only Novartis (Diovan Hct 08)

Packaging label for Diovan HCT 160 mg/12.5 mg film-coated tablets by Novartis Pharmaceuticals Corporation. The label includes dosage instructions, storage conditions, manufacturer and distributor information, and a barcode. The package contains 90 tablets.*

FDA Label Image

Principal Display Panel Ndc 0078-0383-34 Diovan Hct® Valsartan And Hydrochlorothiazide, Usp 160 mg/25 mg 90 Tablets Rx Only Novartis (Diovan Hct 0a)

Label for Diovan HCT tablets containing valsartan and hydrochlorothiazide, USP, with a strength of 160 mg/25 mg. The packaging indicates a count of 90 film-coated oral tablets, manufactured by Patheon Manufacturing Services LLC and distributed by Novartis Pharmaceuticals Corporation. Storage instructions and the NDC 0078-0383-34 are also shown.*

FDA Label Image

Principal Display Panel Ndc 0078-0471-34 Diovan Hct® Valsartan And Hydrochlorothiazide, Usp 320 mg/12.5 mg 90 Tablets Rx Only Novartis (Diovan Hct 0b)

Diovan HCT 320 mg/12.5 mg film-coated tablets carton label. Contains valsartan and hydrochlorothiazide USP. Package includes 90 tablets for oral use. Label shows NDC 0078-0471-34 and is distributed by Novartis Pharmaceuticals Corporation. Storage and dosage instructions are included with the package.*

FDA Label Image

Principal Display Panel Ndc 0078-0472-34 Diovan Hct® Valsartan And Hydrochlorothiazide, Usp 320 mg/25 mg 90 Tablets Rx Only Novartis (Diovan Hct 0c)

Packaging label for Diovan HCT 320 mg/25 mg film-coated tablets. The label indicates the active ingredients valsartan and hydrochlorothiazide, USP, with a package count of 90 tablets. It includes storage instructions, manufacturer (Patheon Manufacturing Services LLC) and distributor (Novartis Pharmaceuticals Corporation) information, and the Novartis logo. The label also displays the NDC 0078-0472-34 and barcode with lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.